Progress in the management of bone metastases: One continent at a time?

被引：7

作者：

Hortobagyi, GN ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 15期

关键词：

D O I：

10.1200/JCO.2005.11.931

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3299 / 3301

页数：3

共 25 条

[1]

Baum M, 2002, LANCET, V359, P2131

[2]

Berenson James R., 1998, Current Opinion in Oncology, V10, P566, DOI 10.1097/00001622-199811000-00015

[3]

Boissier S, 2000, CANCER RES, V60, P2949

[4] Metastatic bone disease: clinical features, pathophysiology and treatment strategies [J].

Coleman, RE .

CANCER TREATMENT REVIEWS, 2001, 27 (03) :165-176

[5] Protein geranylgeranylation is required for osteoclast formation, function, and survival: Inhibition by bisphosphonates and GGTI-298 [J].

Coxon, FP ;

Helfrich, MH ;

Van't Hof, R ;

Sebti, S ;

Ralston, SH ;

Hamilton, A ;

Rogers, MJ .

JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (08) :1467-1476

[6] An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis [J].

Giraudo, E ;

Inoue, M ;

Hanahan, D .

JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (05) :623-633

[7]

GORDON D, 2003, P AN M AM SOC CLIN, V22, P47

[8] The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer [J].

Greep, NC ;

Giuliano, AE ;

Hansen, NM ;

Taketani, T ;

Wang, HJ ;

Singer, FR .

AMERICAN JOURNAL OF MEDICINE, 2003, 114 (08) :653-659

[9] Farnesyl transferase inhibitors as anticancer agents [J].

Haluska, P ;

Dy, GK ;

Adjei, AA .

EUROPEAN JOURNAL OF CANCER, 2002, 38 (13) :1685-1700

[10]

Hiraga T, 2001, CANCER RES, V61, P4418

← 1 2 3 →